Notes: February, 5 2019 -- Pulmatrix, Inc. (PULM) has announced a 1-for-10 reverse stock split. As a result of the reverse stock split, each PULM Common Share will be converted into the right to receive 0.10 (New) Pulmatrix, Inc. Common Shares. The reverse stock split will become effective before the market open on February 6, 2019. <p> June 15, 2015 -- The reverse merger between Ruthigen, Inc. and Pulmatrix, Inc. is expected to close today, June 15, 2015. Ruthigen, Inc. (RTGN) will undergo a one for two and a half (1-2.5) reverse split of its common stock as well as a name, symbol, and CUSIP change effective June 16, 2015. </p> March 16, 2015 - Ruthigen, Inc. (NASDAQ: RTGN) and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company, announced today that they have entered into a definitive merger agreement. Upon satisfaction of the closing conditions contained in the merger agreement, Pulmatrix will become a wholly-owned subsidiary of Ruthigen and all of Pulmatrix’s debt and equity securities outstanding prior to the consummation of the merger will be exchanged for shares of Ruthigen common stock that will represent approximately 81% of the outstanding common stock of Ruthigen. Upon completion of the merger, Ruthigen will be renamed Pulmatrix, Inc. and, pending NASDAQ approval of Pulmatrix’s initial listing application in connection with the merger, the surviving company’s common stock will continue to trade on The NASDAQ Capital Market after the merger. It is anticipated that the combined company will focus its resources and efforts on the development of Pulmatrix’s next-generation inhaled therapeutic products.